Mirabegron 70518-4304
Product NDC
70518-4304- Manufacturer
- Remedyrepack Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 7, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA209488
Need to source Mirabegron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirabegron | 50 mg/1 |
Drug Class
beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(1)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4304-0)